Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Stuve

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
International Journal of Molecular Sciences|January 10, 2026
Leptin as a Potential Modifier of Neuroinflammation: Contrasting Roles in Alzheimer's Disease and Multiple SclerosisNaghmeh Abbasi Kasbi, Barbara Elena Stopschinski, Alanna Gabrielle Polyak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2012
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic successBenjamin M Greenberg, Donna Graves, Gina Remington, et al.
The Lancet. Neurology|January 22, 2008
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinicianAaron Boster, Gilles Edan, Elliott Frohman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of cancer in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 25, 2014
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Nadia Reider, Olaf Stuve, et al.
Expert Review of Neurotherapeutics|March 25, 2015
Dimethyl fumarate in relapsing-remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safetyDuvyanshu Dubey, Bernd C Kieseier, Hans P Hartung, et al.
Plos One|May 1, 2008
Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patientsKaren Yao, Susan Gagnon, Nahid Akhyani, et al.
Journal of Neuroimmunology|July 25, 2006
Statins in the treatment of central nervous system autoimmune diseaseMartin S Weber, Sawsan Youssef, Shannon E Dunn, et al.
Acta Neuropathologica Communications|October 11, 2022
Tau seeding in cases of multiple sclerosisMichael S LaCroix, Hilda Mirbaha, Ping Shang, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
International Journal of Molecular Sciences|January 10, 2026
Leptin as a Potential Modifier of Neuroinflammation: Contrasting Roles in Alzheimer's Disease and Multiple SclerosisNaghmeh Abbasi Kasbi, Barbara Elena Stopschinski, Alanna Gabrielle Polyak, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2012
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic successBenjamin M Greenberg, Donna Graves, Gina Remington, et al.
The Lancet. Neurology|January 22, 2008
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinicianAaron Boster, Gilles Edan, Elliott Frohman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2014
A systematic review of the incidence and prevalence of cancer in multiple sclerosisRuth Ann Marrie, Nadia Reider, Jeffrey Cohen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 25, 2014
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic reviewRuth Ann Marrie, Nadia Reider, Olaf Stuve, et al.
Expert Review of Neurotherapeutics|March 25, 2015
Dimethyl fumarate in relapsing-remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safetyDuvyanshu Dubey, Bernd C Kieseier, Hans P Hartung, et al.
Plos One|May 1, 2008
Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patientsKaren Yao, Susan Gagnon, Nahid Akhyani, et al.
Journal of Neuroimmunology|July 25, 2006
Statins in the treatment of central nervous system autoimmune diseaseMartin S Weber, Sawsan Youssef, Shannon E Dunn, et al.
Acta Neuropathologica Communications|October 11, 2022
Tau seeding in cases of multiple sclerosisMichael S LaCroix, Hilda Mirbaha, Ping Shang, et al.
Pageof 9